Neisseria lactamica protects against experimental meningococcal infection. - Wikidata - awgldk - TriplyDB

Neisseria lactamica protects against experimental meningococcal infection.

Neisseria lactamica protects against experimental meningococcal infection.

http://www.wikidata.org/entity/Q34126031

about

Prospects for vaccine prevention of meningococcal infection Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.Review of meningococcal group B vaccines.Genetic diversity and carriage dynamics of Neisseria lactamica in infants Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.Oropharyngeal Colonization With Neisseria lactamica, Other Nonpathogenic Neisseria Species and Moraxella catarrhalis Among Young Healthy Children in Ahvaz, Iran.Meningococcal serogroup B infections: a search for a broadly protective vaccine.Serologic correlates of protection for evaluating the response to meningococcal vaccines.The amino acid sequence of Neisseria lactamica PorB surface-exposed loops influences Toll-like receptor 2-dependent cell activation.Towards an improved serogroup B Neisseria meningitidis vaccine.Evolutionary and genomic insights into meningococcal biology.Prospects for eradication of meningococcal disease Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis Vaccine development against Neisseria meningitidis.Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.Neisseria lactamica antigens complexed with a novel cationic adjuvant Challenges and progress in the development of a serogroup B meningococcal vaccine.Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.A common gene pool for the Neisseria FetA antigen.Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.Universal vaccines: shifting to one for many or shooting too high too soon!Neisseria meningitidis B vaccines.Outer membrane vesicle: a macromolecule with multifunctional activity.Neisseria lactamica attenuates TLR-1/2-induced cytokine responses in nasopharyngeal epithelial cells using PPAR-γ.Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling.Insight into proteomic investigations of Neisseria meningitidis serogroup C strain L91543 from analysis of its genome sequence.The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.Impact of Moderate Temperature Changes on Neisseria meningitidis Adhesion Phenotypes and Proteome.Neisserial outer membrane vesicles bind the coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 and suppress CD4+ T lymphocyte function.

P2860

Q24537338-2FB5849A-925C-44EA-9630-A7EB7CCF32B9 Q30150784-C2F41B8D-43DA-40B1-BC49-9C7F5CCFFE42 Q30227840-7329DB01-F1D8-4841-B020-3623CDB284AA Q33646965-EDA6AD18-AD85-4130-B9D3-25874BB0E146 Q33769344-395EE375-E4A0-4447-80CE-6A8F95154CFC Q33913053-5815D224-B756-4658-893F-3CD96B2635F8 Q35217627-21406F2D-AE7A-4159-BAC4-F36F3D4F411F Q35564693-10F4A3D9-4CDF-4160-93E8-2475029C2095 Q35623304-135F3065-F460-4C14-B5DA-1C380EAD444B Q35648260-2BE7ADC3-B24B-4813-822A-36E987427852 Q36277379-99994615-6086-415D-9A82-62FAD1DFD9DA Q36327065-B1C8DE92-7C0B-4661-998F-654FA9ACA186 Q36382175-26988F0B-A794-4337-96A2-99CED00C246C Q36440358-174A3E8D-DF9F-49E5-BECC-1872DD093646 Q36455841-1E08B660-D78B-4DCF-B36A-19C92C42417F Q37274707-6E622C27-0F92-4C6C-9B31-CBE31A02066A Q37336004-A40146BE-D019-4278-9FDB-111E548ADFE3 Q37478314-2405953C-29C5-4DE6-BDF9-FF212E4D0001 Q37503243-7F1DF280-6EC2-432D-8FCA-931C126EE150 Q37582852-AAA226BC-33D3-4484-8E53-12736E837893 Q37669807-6940EA45-FA80-4B0A-B744-B9A6CB966DB0 Q37798011-8444CB80-9D53-4519-9FA6-B56F1C37F60E Q37919551-13139913-2C08-41AB-A511-EA925FA47B5F Q37932528-45450E2E-3182-4781-9CBE-3653F3CFA2B6 Q38018822-1EC2ECC3-D061-492A-BC8F-9D7DCB1B5459 Q39628101-D17E932A-DDC9-41F9-86AC-D93A9DA93250 Q39645647-ACE38EF4-B6BF-4D8E-87E6-8FF20D7635C9 Q41110531-B6A892C0-A285-4AA2-932F-FB279CF7835D Q41963209-D9B38093-9F70-45F3-8E58-3140EA50709B Q42365570-6E35E483-B478-460F-9F7D-567C313C8238 Q42413093-5C8142D0-CC51-429B-BF5C-5F91175D03B2

P2860

Neisseria lactamica protects against experimental meningococcal infection.

http://www.wikidata.org/entity/Q34126031

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Neisseria lactamica protects against experimental meningococcal infection.

@ast

Neisseria lactamica protects against experimental meningococcal infection.

@en

Neisseria lactamica protects against experimental meningococcal infection.

@nl

type

label

Neisseria lactamica protects against experimental meningococcal infection.

@ast

Neisseria lactamica protects against experimental meningococcal infection.

@en

Neisseria lactamica protects against experimental meningococcal infection.

@nl

prefLabel

Neisseria lactamica protects against experimental meningococcal infection.

@ast

Neisseria lactamica protects against experimental meningococcal infection.

@en

Neisseria lactamica protects against experimental meningococcal infection.

@nl

P1433

Q34126031-E30C5D3F-8EF3-44E9-A903-8C4155C256F2

P1476

Q34126031-9B45A416-2CA3-4F9E-8976-FE2E6751312D

P2093

Q34126031-28C8C498-3B94-459D-A4F1-FD898FD234EE

Q34126031-5AB23C96-24C1-485C-8BCE-1E975D945859

Q34126031-79D01727-D621-4321-A6B3-AB08D5E2C37D

Q34126031-A69473D0-52EC-40B8-B7FA-175D4EA91579

Q34126031-E951202E-C9B6-454D-BA62-57784CD9E7DC

Q34126031-F453ED5B-34A6-4692-A06F-2DFF538A7558

Q34126031-F52739CE-CB13-4A97-8306-26E92A626C5F

Q34126031-F9E9E13C-C3F6-4264-9C53-D00A67388595

P2860

Q34126031-0097D4E0-52EF-4DB6-AB66-E26D2C6C88EE

Q34126031-192FC372-8C4B-43DD-9130-562AFFCB688B

Q34126031-214A9273-AC39-45F1-85B1-859932E597B3

Q34126031-35D2C22D-21C7-4444-9F09-17243D3E2DF4

Q34126031-4B51B740-2F03-4EB8-8BF3-C8950B1BFF10

Q34126031-540639AC-2C7F-4B0C-83E4-E8E06BE0E216

Q34126031-5C552B79-48AA-4850-BEAA-19D6F0A9729D

Q34126031-60FA4601-35F2-4083-9519-429FFF1E1F43

Q34126031-6C85A6F0-FEDC-4538-913F-AE8CACA3740C

Q34126031-9536545F-4839-4D5D-8393-A88ACA1E70A9

P304

Q34126031-B63222C7-59DC-4B76-A394-56A380BE23BA

P31

Q34126031-573055CB-8C80-438A-B5C0-B92D7FCBC422

P356

Q34126031-51A76C0B-9089-4371-8708-4944D4132131

P407

Q34126031-1D5AB37C-E80F-4BD4-AB34-0B0C02202F4E

P433

Q34126031-BDE11DC0-F874-44BB-BFE9-C296792B2F44

P478

Q34126031-043B1200-D043-4269-B869-36C912697D81

P50

Q34126031-35005D08-2499-4D2B-8FEE-E3A223AE22B2

P577

Q34126031-5BC10B62-836E-4B0D-94C1-F34951A451E2

P5875

Q34126031-A8FE4937-56B3-4F2C-8B3C-F4EE5E8D7BAE

P698

Q34126031-087A5A73-F80A-407A-931F-1A6B728DB623

P932

Q34126031-4072DBE3-3BA7-421E-A19A-9B42F1042278

P356

IAI.70.7.3621-3626.2002

P1433

Infection and Immunity

P1476

Neisseria lactamica protects against experimental meningococcal infection.

@en

P2093

Andrew R Gorringe

http://www.w3.org/2001/XMLSchema#string

Andrew Robinson

http://www.w3.org/2001/XMLSchema#string

Ian M Feavers

http://www.w3.org/2001/XMLSchema#string

Karen M Reddin

http://www.w3.org/2001/XMLSchema#string

Keith Cartwright

http://www.w3.org/2001/XMLSchema#string

Kerry J Oliver

http://www.w3.org/2001/XMLSchema#string

Michael J Hudson

http://www.w3.org/2001/XMLSchema#string

Philippa Bracegirdle

http://www.w3.org/2001/XMLSchema#string

P2860

Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes

Human immunity to the meningococcus. I. The role of humoral antibodies.

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica.

Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease.

Septicemia due to Neisseria lactamica.

Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

P304

3621-3626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.7.3621-3626.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11308086

http://www.w3.org/2001/XMLSchema#string

P698

12065503

http://www.w3.org/2001/XMLSchema#string

P932

128090

http://www.w3.org/2001/XMLSchema#string